Related Experiment Videos
General practice aspects of Intal treatment
1University of Glasgow, Department of General Practice, U.K.
Respiratory Medicine
|May 1, 1989
Summary
This study identified the typical patient receiving Intal (cromoglicate) in Scottish general practices. The common Intal user was a young male, aged 5-9, using a Spinhaler and bronchodilators but not corticosteroids.
Area of Science:
- Pharmacology
- General Practice
- Respiratory Medicine
Background:
- Intal (cromoglicate) is a medication used for asthma management.
- Understanding patient profiles aids in optimizing therapeutic strategies.
Purpose of the Study:
- To analyze the demographic and therapeutic characteristics of patients prescribed Intal in two Scottish general practices.
- To define the profile of a typical Intal recipient in a primary care setting.
Main Methods:
- Retrospective analysis of patient data from two Scottish general practices.
- Data collected included patient age, sex, delivery system (Spinhaler), and concurrent therapies (bronchodilators, corticosteroids).
Main Results:
- The 'typical' Intal patient was identified as a male, aged 5-9 years.
- This patient profile was associated with the use of a Spinhaler delivery system.
- Concurrent use of bronchodilators was common, whereas corticosteroid use was not.
Conclusions:
- The study provides insights into the real-world prescribing patterns of Intal in general practice.
- The findings suggest a specific demographic and therapeutic profile for Intal users, primarily young males using Spinhalers.
- This characterization may inform future asthma management guidelines and resource allocation in primary care.